Skip to main content

Table 1 Correlation between AZGP1 expression and clinical and pathological characters in HCC

From: Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis

Variable

AZGP1 protein

 

All cases

Low expression

High expression

 χ  2

P valueα

Age(years) b

   

0.134

0.714

  48

119

46 (38.7)

73 (61.3)

  

  ≥ 48

127

52 (40.9)

75 (59.1)

  

Mean ± SD(47.9 ± 11.8)

     

Gender

   

0.099

0.753

  Female

27

10 (37.0)

17(63.0)

  

  Male

219

88(40.2)

131(59.8)

  

HBsAg

   

0.673

0.412

  Yes

213

87 (40.8)

126 (59.2)

  

  No

33

11(33.3)

22 (66.7)

  

AFP (ng/ml)

   

6.182

0.013

  ≤ 20

104

32 (30.8)

72 (69.2)

  

  > 20

142

66 (46.5)

76 (53.5)

  

Liver cirrhosis

   

9.244

0.002

  Yes

177

81 (45.8)

96 (54.2)

  

  No

69

17 (24.6)

52 (75.4)

  

Tumor size (cm)

   

0.457

0.499

  ≤ 5

127

48 (37.8)

79 (62.2)

  

  > 5

119

50 (42.0)

69 (58.0)

  

Tumor multiplicity

   

0.042

0.837

  Single

130

51 (39.2)

79 (60.8)

  

  Multiple

116

47 (40.5)

69 (59.5)

  

Tumor differentiation

   

9.347

0.025

  Well (I)

33

6 (18.2)

27 (81.8)

  

  Moderate (II)

125

54 (43.2)

71 (56.8)

  

  Poor (III)

76

35 (46.1)

41 (53.9)

  

Undifferentiation (IV)

12

3 (25)

9 (75)

  

Clinical Stage

   

2.154

0.541

  I

16

5 (31.3)

11 (68.7)

  

  II

93

33 (35.5)

60 (61.5)

  

  III

106

46 (43.4)

60 (56.6)

  

  IV

31

14 (45.2)

17 (54.8)

  

Vascular invasion

   

1.966

0.161

  Yes

73

34 (46.6)

39 (53.4)

  

  No

173

64 (37.0)

109 (63.0)

  
  1. αChi-square test; b patients were divided according to the median age; AFP, alpha-fetoprotein; HBsAg, hepatitis B surface antigen; AZGP1, zinc-alpha2-glycoprotein.